About Us
Company History
Vision & Values
XenoGesis & Sygnature Discovery
Services
At a Glance
In vitro
DMPK & Pharmacology
Physicochemical Properties
Chemical Stability
In vitro
Binding
Metabolic Stability
Permeability & Transporter Services
Reaction Phenotyping
CYP Inhibition
CYP Induction
Pharmacology Assay Development
Customised Laboratory Services
PK, Bioanalysis & Metabolite Identification
Bioanalysis Overview
Bioanalysis Services
Metabolite Identification
Pharmacokinetics (PK)
Metabolite Bulk-Up & Isolation (mg to g)
Modelling & Simulation
ADME Packages
Pharmacokinetics
Absorption
Oral Exposure
Human PK & Dose Prediction
Formulation Services
Due Diligence
Hit/Lead Compounds
Clinical Candidate
Latest
Blog
Events
News
Partners
Axis BioServices
Medicines Discovery Catapult
Reach Separations
Saretius
TherapeutAix
Meet The Team
Resources
Articles
Posters
Presentations
Publications
Videos
Contact Us
Join Us
Consultancy
The Best of Both Worlds: Innovation and collaboration between CROs and their clients
CCS1477: Inhibitor for late-stage prostate cancer enters clinic
XenoGesis supported TropIQ research into vector-borne disease control
XenoGesis to expand into Discovery Building
Richard Weaver to MC LATi event
The importance of early dose prediction
Resolving your R&D challenges
XenoGesis experiences continued growth
XenoGesis moves into BioHub as expansion plans continue
2017 in review – a cracker!
Posts navigation
1
2
Next Page
About Us
Company History
Vision & Values
XenoGesis & Sygnature Discovery
Services
At a Glance
In vitro
DMPK & Pharmacology
Physicochemical Properties
Chemical Stability
In vitro
Binding
Metabolic Stability
Permeability & Transporter Services
Reaction Phenotyping
CYP Inhibition
CYP Induction
Pharmacology Assay Development
Customised Laboratory Services
PK, Bioanalysis & Metabolite Identification
Bioanalysis Overview
Bioanalysis Services
Metabolite Identification
Pharmacokinetics (PK)
Metabolite Bulk-Up & Isolation (mg to g)
Modelling & Simulation
ADME Packages
Pharmacokinetics
Absorption
Oral Exposure
Human PK & Dose Prediction
Formulation Services
Due Diligence
Hit/Lead Compounds
Clinical Candidate
Latest
Blog
Events
News
Partners
Axis BioServices
Medicines Discovery Catapult
Reach Separations
Saretius
TherapeutAix
Meet The Team
Resources
Articles
Posters
Presentations
Publications
Videos
Contact Us
Join Us